Dr. Lucian V. Del Priore, MD

Dr. Del Priore practices at Yale Medicine in New Haven, Connecticut.

Dr. Del Priore's NPI, 1790702769, was assigned on July 16, 2006. Dr. Del Priore graduated from University of Rochester School of Medicine and Dentistry in 1982. Dr. Del Priore holds Connecticut license 55473.

Dr. Del Priore's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Del Priore's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Del Priore is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Del Priore to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Del Priore practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Del Priore's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Del Priore's licenses on file in 3 states: Connecticut, New Jersey and South Carolina.

CMS data shows 421 Medicare services from Dr. Del Priore across 6 procedure codes in 2024, for 151 Medicare patients. Medicare paid $24,971 for them. Every service was in an office.

CMS counts 151 Medicare patients who saw Dr. Del Priore in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Del Priore's median patient age at 69, with 49% women.

In 2024, Dr. Del Priore wrote 139 Medicare Part D claims for 45 patients. 58% of them were for generic drugs. CMS names the drug for 105 of them, across 5 drugs with 11 or more claims each, at $3,832 in total drug cost. In 2023, CMS named 70 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Del Priore for performance year 2024, reported as part of a group. Dr. Del Priore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Del Priore as offering telehealth.

Dmand AI links 40 papers to Dr. Del Priore, published from 2003 to 2024. 2015 was the busiest year, with 5. The most frequent topics are Macular Degeneration, Retinal Pigment Epithelium and Induced Pluripotent Stem Cells. Dr. Del Priore has published most often in Invest Ophthalmol Vis Sci. Dr. Del Priore's most frequent co-authors are Liangbo Shen, MD, Jacque L. Duncan, MD and Ron Afshari Adelman, MD.

CMS Open Payments shows 5 general payments to Dr. Del Priore from 3 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 89% of the total. Boehringer Ingelheim USA, Inc. paid the most, $8,996.

Dr. Del Priore graduated from University of Rochester School of Medicine and Dentistry in 1982.